Phase 1 Study of Mesothelin-ADC
NCT02884726 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2020-03-19
Summary
The purpose of this study is to assess the safety and tolerability of Mesothelin-ADC in subjects with advanced and/or metastatic solid tumors.
Conditions
Interventions
- DRUG
-
BMS-986148
Specified dose on specified days
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-14
- Primary Completion
- 2017-09-06
- Completion
- 2017-09-06
Countries
- Japan
More Related Trials
-
BMS-214662 in Treating Patients With Advanced Solid Tumors
NCT00004877 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MHB042C in Patients With Advanced Solid Tumors
NCT07192107 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I (PH I) Mad Refractory Solid Tumor Study
NCT00099606 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors
NCT05389462 ·Status: TERMINATED ·Phase: PHASE1
-
Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan
NCT00898716 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005)
NCT01226901 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
NCT07160725 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
NCT00886782 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study of MHB048C in Patients With Advanced Solid Tumors
NCT07192120 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Japanese Phase 1 Study of BMS-844203 (CT322)
NCT01146171 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study Evaluating MST-997 in Advanced Malignant Solid Tumors
NCT00088647 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of TAK-103 in Adult With Solid Tumors
NCT05164666 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)
NCT01463696 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of MHB009C in Patients With Advanced Solid Tumors
NCT07326488 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors
NCT00355888 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan
NCT00742105 ·Status: TERMINATED ·Phase: PHASE1
-
Phase I Study of MK-1496 in Patients With Advanced Solid Tumor (MK-1496-002 AM 4)(COMPLETED)
NCT00880568 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors
NCT01413906 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
NCT05094336 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
SD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid Malignancies
NCT03831295 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation
NCT07060989 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan
NCT01018745 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors
NCT01014429 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
NCT06476808 ·Status: RECRUITING ·Phase: PHASE1
-
Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors
NCT05148325 ·Status: COMPLETED ·Phase: PHASE1